Kodak stock sinks 45% after alleged insider trading halts its pharma pivot

Eastman Kodak stock is down nearly 45% during Monday’s pre-market trade after the US government signalled alleged insider trading has jeopardised its pivot into pharmaceuticals. “On July 28, we signed a Letter of Interest with Eastman Kodak,” tweeted the US International Development Finance Corporation (DFC) on Friday. “Recent allegations of wrongdoing raise serious concerns. We will not proceed any further unless these allegations are cleared.” On July 28, we sign